Rebecca M. Chatwin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Rebecca M. Chatwin has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Benjamin T. Gillard
Translational Health Sciences, Bristol Medical School, Dorothy Hodgkin Building University of Bristol, BS8 1TD, United Kingdom
1 shared publication - Bianca H. Ventura Fernandes
School of Biochemistry and Biomedical Sciences, Biomedical Sciences Building, University of Bristol, BS8 1TD, United Kingdom
1 shared publication - Borko Amulic
School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK
1 shared publication - Christina Lindsey Hammond
School of Physiology, Pharmacology and Neuroscience University of Bristol Bristol UK
1 shared publication - Christopher P. Jones
Interface Analysis Centre, School of Physics, H. H. Wills Physics Laboratory University of Bristol, Bristol, BS8 1TL, UK
1 shared publication - Joanna J. Moss
School of Biochemistry and Biomedical Sciences, University of Bristol, Biomedical Science Building, Bristol, UK
1 shared publication
Latest Publications
- Open Access
Ibuprofen impairs fracture healing by disrupting neutrophil-mediated tissue repair
Neutrophils are among the first immune cells recruited to fractures, yet their contribution to bone repair remains poorly understood. Anti-inflammatory use has been linked to increased risk of non-union fractures, while prolonged neutrophil activity or failed clearance of neutrophil-derived DNA in the form of neutrophil extracellular traps (NETs), can also impair fracture healing. Using dynamic live imaging and cellular perturbation in adult zebrafish, we show that neutrophils play a key role in shaping the early fracture microenvironment. Neutrophils rapidly accumulated at fractures where they released NETs and exhibited the activation of gene programmes associated with matrix remodelling. Compromising neutrophil recruitment, via ibuprofen treatment or orthogonal genetic and pharmacological perturbations, dramatically increased incidence of fracture non-union and lead to altered callus architecture through delay of osteoblast differentiation and impaired mineralisation. Mechanistically, neutrophils actively interacted with key structural proteins, including laminin, fibronectin, and collagen I, through uptake, recycling and active de novo secretion pathways. Together, our findings reveal that neutrophils establish a provisional emergency fracture matrix that templates subsequent bone repair, providing a mechanistic link between early non-steroidal anti-inflammatory drug (NSAID) exposure and impaired skeletal healing.
Open AccessIbuprofen impairs fracture healing by disrupting neutrophil-mediated tissue repair
Neutrophils are among the first immune cells recruited to fractures, yet their contribution to bone repair remains poorly understood. Anti-inflammatory use has been linked to increased risk of non-union fractures, while prolonged neutrophil activity or failed clearance of neutrophil-derived DNA in the form of neutrophil extracellular traps (NETs), can also impair fracture healing. Using dynamic live imaging and cellular perturbation in adult zebrafish, we show that neutrophils play a key role in shaping the early fracture microenvironment. Neutrophils rapidly accumulated at fractures where they released NETs and exhibited the activation of gene programmes associated with matrix remodelling. Compromising neutrophil recruitment, via ibuprofen treatment or orthogonal genetic and pharmacological perturbations, dramatically increased incidence of fracture non-union and lead to altered callus architecture through delay of osteoblast differentiation and impaired mineralisation. Mechanistically, neutrophils actively interacted with key structural proteins, including laminin, fibronectin, and collagen I, through uptake, recycling and active de novo secretion pathways. Together, our findings reveal that neutrophils establish a provisional emergency fracture matrix that templates subsequent bone repair, providing a mechanistic link between early non-steroidal anti-inflammatory drug (NSAID) exposure and impaired skeletal healing.